Breaking News Instant updates and real-time market news.

VNDA

Vanda

$16.25

0.02 (0.12%)

06:14
10/06/16
10/06
06:14
10/06/16
06:14

Vanda assumed with a Buy at Jefferies

Jefferies analyst Matthew Andrews assumed coverage of Vanda Pharmaceuticals with a Buy rating and raised his price target for the shares to $23 from $15. The analyst sees further upside in the stock as U.S. Fanapt sales continue improving and Hetlioz sees "steady" growth.

VNDA Vanda
$16.25

0.02 (0.12%)

03/23/16
JEFF
03/23/16
NO CHANGE
JEFF
Jefferies believes most of the biotech downside has already occurred
The Jefferies Biotechnology team, led by Brian Abrahams, believes most of the significant downside in Biotechnology shares has already occurred with the iShares NASDAQ Biotechnology Index (IBB) down 22% year-to-date. Nonetheless, volatility in the space could persist with funds flowing out of healthcare and negative drug pricing rhetoric, the analysts tell investors in a research note. They view any weakness in the space as "excellent" long-term buying opportunities for companies with "concrete" earnings outlooks and "promising" pipelines. The analysts highlight Vertex (VRTX), BioMarin (BMRN), The Medicines Co. (MDCO), Ultragenyx (RARE) and Vanda (VNDA) as names to focus on.
08/25/16
PIPR
08/25/16
NO CHANGE
Target $19
PIPR
Overweight
Vanda price target raised to $19 from $16 at Piper Jaffray
Piper Jaffray analyst Joshua Schimmer raised his price target on Vanda Pharmaceuticals to $19 from $16, calling its patent victory related to Fanapt a "major upside surprise."
08/26/16
JMPS
08/26/16
NO CHANGE
JMPS
Vanda price target raised to $22 from $18 at JMP Securities
JMP Securities analyst Jason Butler raised his price target on Vanda after the company won a favorable verdict in the trial over the generic version of Fanapt. The analyst calls the ruling "a substantial victory" for the company and keeps an Outperform rating on the shares.
09/30/16
PIPR
09/30/16
NO CHANGE
Target $19
PIPR
Overweight
Piper sees gastroparesis as another reason to own Vanda
Piper Jaffray analyst Joshua Schimmer says that one abstract from the American College of Gastroenterology published yesterday highlighted the results of the Phase 3 APRON study and potential of the NK-1 receptor antagonist aprepitant for the treatment of gastroparesis. The data show "encouraging signs of efficacy" for the mechanism and suggest a path forward for Vanda Pharmaceuticals' own NK-1 receptor antagonist tradipitant, Schimmer tells investors in a research note. He believes tradipitant represents an underappreciated part of the Vanda story and views the company's potential in gastroparesis as another reason to own the shares. Schimmer reiterates an Overweight rating on Vanda with a $19 price target.

TODAY'S FREE FLY STORIES

ICON

Iconix Brand

$6.62

0.12 (1.85%)

09:50
06/26/17
06/26
09:50
06/26/17
09:50
Conference/Events
Iconix Brand management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

SVA

Sinovac Biotech

$5.70

-0.02 (-0.35%)

09:50
06/26/17
06/26
09:50
06/26/17
09:50
Hot Stocks
Breaking Hot Stocks news story on Sinovac Biotech »

Sinovac Biotech trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CECE

CECO Environmental

$9.34

0.09 (0.97%)

09:48
06/26/17
06/26
09:48
06/26/17
09:48
Conference/Events
CECO Environmental management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

PRTS

U.S. Auto Parts

$3.23

0.01 (0.31%)

09:47
06/26/17
06/26
09:47
06/26/17
09:47
Conference/Events
U.S. Auto Parts management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

SGEN

Seattle Genetics

$61.74

-1.51 (-2.39%)

09:46
06/26/17
06/26
09:46
06/26/17
09:46
Recommendations
Seattle Genetics analyst commentary  »

Piper says Seattle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

MLM

Martin Marietta

09:44
06/26/17
06/26
09:44
06/26/17
09:44
Technical Analysis
Technical View: Martin Marietta up after Bluegrass Materials acquisition »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

F

Ford

09:42
06/26/17
06/26
09:42
06/26/17
09:42
Conference/Events
Ford to host sales conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jul

  • 26

    Jul

AAOI

Applied Optoelectronics

$65.87

2.29 (3.60%)

, MTSI

MACOM

$58.26

1.76 (3.12%)

09:40
06/26/17
06/26
09:40
06/26/17
09:40
Recommendations
Applied Optoelectronics, MACOM, Fabrinet, Amazon.com analyst commentary  »

Needham says Applied…

AAOI

Applied Optoelectronics

$65.87

2.29 (3.60%)

MTSI

MACOM

$58.26

1.76 (3.12%)

FN

Fabrinet

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 12

    Jul

  • 13

    Jul

  • 29

    Aug

AAPL

Apple

$146.28

0.65 (0.45%)

09:40
06/26/17
06/26
09:40
06/26/17
09:40
Technical Analysis
Technical View: Apple rises, levels to watch »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

LOW

Lowe's

, VRX

Valeant

09:40
06/26/17
06/26
09:40
06/26/17
09:40
Options
Unusually active option classes on open June 26th »

Unusual total active…

LOW

Lowe's

VRX

Valeant

CSCO

Cisco

$32.09

0.24 (0.75%)

BIDU

Baidu

$178.14

-1.19 (-0.66%)

P

Pandora

NKE

Nike

TWTR

Twitter

COST

Costco

$157.13

-2.66 (-1.66%)

GLD

SPDR Gold Trust

AAPL

Apple

$146.28

0.65 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 12

    Jul

  • 12

    Jul

  • 13

    Jul

  • 19

    Jul

  • 16

    Aug

  • 23

    Aug

  • 24

    Aug

09:40
06/26/17
06/26
09:40
06/26/17
09:40
General news
Vehicle Inventories Pose Risk For Auto Retooling »

Vehicle Inventories Pose…

ARNC

Arconic

09:38
06/26/17
06/26
09:38
06/26/17
09:38
Technical Analysis
Technical View: Arconic trades sharply lower »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCAP

Triangle Capital

09:37
06/26/17
06/26
09:37
06/26/17
09:37
Upgrade
Triangle Capital rating change  »

Triangle Capital upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FE

FirstEnergy

09:35
06/26/17
06/26
09:35
06/26/17
09:35
Upgrade
FirstEnergy rating change  »

FirstEnergy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FN

Fabrinet

, AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

09:35
06/26/17
06/26
09:35
06/26/17
09:35
Recommendations
Fabrinet, Amazon.com, Tesla analyst commentary  »

Fabrinet price target…

FN

Fabrinet

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

TSLA

Tesla

$383.45

0.84 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 12

    Jul

  • 13

    Jul

  • 29

    Aug

  • 02

    Oct

SGEN

Seattle Genetics

$61.74

-1.51 (-2.39%)

09:31
06/26/17
06/26
09:31
06/26/17
09:31
Recommendations
Seattle Genetics analyst commentary  »

Seattle Genetics data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

MDXG

MiMedx

$15.71

0.14 (0.90%)

09:30
06/26/17
06/26
09:30
06/26/17
09:30
Recommendations
MiMedx analyst commentary  »

MiMedx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

, COST

Costco

$157.13

-2.66 (-1.66%)

09:28
06/26/17
06/26
09:28
06/26/17
09:28
Conference/Events
Cowen internet and retail analysts hold an analyst/industry conference call »

Internet & New Media…

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

COST

Costco

$157.13

-2.66 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 23

    Aug

CGIX

Cancer Genetics

$3.85

0.05 (1.32%)

09:27
06/26/17
06/26
09:27
06/26/17
09:27
Initiation
Cancer Genetics initiated  »

Cancer Genetics initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROV

Trovagene

$1.14

-0.16 (-12.31%)

09:27
06/26/17
06/26
09:27
06/26/17
09:27
Hot Stocks
Trovagene reports receipt of notice of event of default from lender »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBTX

Independent Bank

$54.85

-1.1 (-1.97%)

09:22
06/26/17
06/26
09:22
06/26/17
09:22
Upgrade
Independent Bank rating change  »

Independent Bank upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

CSCO

Cisco

$32.09

0.24 (0.75%)

09:22
06/26/17
06/26
09:22
06/26/17
09:22
Recommendations
Cisco analyst commentary  »

Cisco intent-based…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 12

    Jul

  • 12

    Jul

  • 13

    Jul

  • 16

    Aug

SPX

S&P 500

, VIX

Volatility Index S&P 500 Options

09:18
06/26/17
06/26
09:18
06/26/17
09:18
Options
Overnight activity included 119 trades in SPX and 25 trades in VIX »

119 trades were executed…

SPX

S&P 500

VIX

Volatility Index S&P 500 Options

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNC

Synacor

, T

AT&T

09:16
06/26/17
06/26
09:16
06/26/17
09:16
Recommendations
Synacor, AT&T analyst commentary  »

AT&T portal ramping…

SYNC

Synacor

T

AT&T

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$71.21

0.95 (1.35%)

09:11
06/26/17
06/26
09:11
06/26/17
09:11
Periodicals
LinkedIn's president of China set to depart, TechCrunch says »

Derek Shen, president of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 20

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.